The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Antibody recycling by engineered pH-dependent antigen binding improves the duration of antigen neutralization
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Maxfield, F. R., & McGraw, T. E. (2004) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1315 · Cited by 1,729
Monoclonal antibodies: versatile platforms for cancer immunotherapy
Weiner, L. M., Surana, R., & Wang, S. (2010) · Nature Reviews Immunology · doi:10.1038/nri2744 · Cited by 1,283
Genovese, M. C., McKay, J. D., Nasonov, E. L., Mysler, E. F., da Silva, N. A., Alecock, E., Woodworth, T., & Gomez‐Reino, J. J. (2008) · Arthritis & Rheumatism · doi:10.1002/art.23940 · Cited by 855
Strategies and challenges for the next generation of therapeutic antibodies
Beck, A., Wurch, T., Bailly, C., & Corvaia, N. (2010) · Nature Reviews Immunology · doi:10.1038/nri2747 · Cited by 847
Therapeutic antibodies for autoimmunity and inflammation
Chan, A. C., & Carter, P. J. (2010) · Nature Reviews Immunology · doi:10.1038/nri2761 · Cited by 837
Enhanced antibody half-life improves in vivo activity
Zalevsky, J., Chamberlain, A. K., Horton, H. M., Karki, S., Leung, I. W. L., Sproule, T. J., Lazar, G. A., Roopenian, D. C., & Desjarlais, J. R. (2010) · Nature Biotechnology · doi:10.1038/nbt.1601 · Cited by 653
Rose-John, S., Scheller, J., Elson, G., & Jones, S. A. (2006) · Journal of Leukocyte Biology · doi:10.1189/jlb.1105674 · Cited by 647
Properties of Human IgG1s Engineered for Enhanced Binding to the Neonatal Fc Receptor (FcRn)
Dall'Acqua, W. F., Kiener, P. A., & Wu, H. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m604292200 · Cited by 646
Hirota, H., Yoshida, K., Kishimoto, T., & Taga, T. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.11.4862 · Cited by 505
Elimination mechanisms of therapeutic monoclonal antibodies
Tabrizi, M. A., Tseng, C.-M. L., & Roskos, L. K. (2006) · Drug Discovery Today · doi:10.1016/s1359-6446(05)03638-x · Cited by 478
Crystal structure of the complex of rat neonatal Fc receptor with Fc
Burmeister, W. P., Huber, A. H., & Bjorkman, P. J. (1994) · Nature · doi:10.1038/372379a0 · Cited by 431
Crystal structure of the complex of rat neonatal Fc receptor with Fc
(1995) · Trends in Genetics · doi:10.1016/0168-9525(95)90005-5 · Cited by 381
Finkelman, F. D., Madden, K. B., Morris, S. C., Holmes, J. M., Boiani, N., Katona, I. M., & Maliszewski, C. R. (1993) · The Journal of Immunology · doi:10.4049/jimmunol.151.3.1235 · Cited by 366
Biodistribution Mechanisms of Therapeutic Monoclonal Antibodies in Health and Disease
Tabrizi, M., Bornstein, G. G., & Suria, H. (2010) · The AAPS Journal · doi:10.1208/s12248-009-9157-5 · Cited by 305
Reshaping a human antibody to inhibit the interleukin 6-dependent tumor cell growth.
Sato, K., Tsuchiya, M., Saldanha, J. W., Koishihara, Y., Ohsugi, Y., Kishimoto, T., & Bendig, M. M. (1993) · PubMed · Cited by 274
Sarkar, C. A., Lowenhaupt, K., Horan, T. P., Boone, T. C., Tidor, B., & Lauffenburger, D. A. (2002) · Nature Biotechnology · doi:10.1038/nbt725 · Cited by 152
Purification and Characterization of Soluble Human IL-6 Receptor Expressed in CHO Cells
Yasukawa, K., Saito, T., Fukunaga, T., Sekimori, Y., Koishihara, Y., Fukui, H., Ohsugi, Y., Matsuda, T., Yawata, H., Hirano, T., et al. (1990) · The Journal of Biochemistry · doi:10.1093/oxfordjournals.jbchem.a123261 · Cited by 145
Self-citationDeng, R., Loyet, K. M., Lien, S., Iyer, S., DeForge, L. E., Theil, F., Lowman, H. B., Fielder, P. J., & Prabhu, S. (2010) · Drug Metabolism and Disposition · doi:10.1124/dmd.109.031310 · Cited by 112
Ng, C. M., Stefanich, E. G., Anand, B. S., Fielder, P. J., & Vaickus, L. (2005) · Pharmaceutical Research · doi:10.1007/s11095-005-8814-3 · Cited by 109
Characterization of anti-mouse interleukin-6 receptor antibody
Okazaki, M., Yamada, Y., Nishimoto, N., Yoshizaki, K., & Mihara, M. (2002) · Immunology Letters · doi:10.1016/s0165-2478(02)00202-x · Cited by 108
Ohsugi, Y., & Kishimoto, T. (2008) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.8.5.669 · Cited by 69
Biosynthesis and half‐life of the interleukin‐6 receptor and its signal transducer gp130
Gerhartz, C., Dittrich, E., Stoyan, T., Rose‐John, S., Yasukawa, K., Heinrich, P. C., & Graeve, L. (1994) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1994.tb18991.x · Cited by 59
Kelley, S. K., Gelzleichter, T. R., Xie, D., Lee, W. P., Darbonne, W. C., Qureshi, F., Kissler, K. M., Oflazoglu, E., & Grewal, I. S. (2006) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706828 · Cited by 59
Kelley, S. K., Gelzleichter, T. R., Xie, D., Lee, W. P., Darbonne, W. C., Qureshi, F., Kissler, K. M., Oflazoglu, E., & Grewal, I. S. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707129 · Cited by 58
Improving Antibody Binding Affinity and Specificity for Therapeutic Development
Boström, J., Lee, C. V., Haber, L., & Fuh, G. (2008) · Methods in molecular biology · doi:10.1007/978-1-59745-554-1_19 · Cited by 48
Maeda, K., Kato, Y., & Sugiyama, Y. (2002) · Journal of Controlled Release · doi:10.1016/s0168-3659(02)00126-8 · Cited by 29
The clinical efficacy of tocilizumab in rheumatoid arthritis
Mircic, M., & Kavanaugh, A. (2009) · Drugs of today · doi:10.1358/dot.2009.45.3.1343794 · Cited by 17
Shinkura, H., Imazeki, I., Yamazaki, M., Oda, Y., Kotoh, M., & Mihara, M. (1998) · PubMed · Cited by 11
Cited by
Trial of Satralizumab in Neuromyelitis Optica Spectrum Disorder
Yamamura, T., Kleiter, I., Fujihara, K., Palace, J., Greenberg, B., Zakrzewska-Pniewska, B., Patti, F., Tsai, C.-P., Saiz, A., Yamazaki, H., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1901747 · Cited by 664
Cancer acidity: An ultimate frontier of tumor immune escape and a novel target of immunomodulation
Huber, V., Camisaschi, C., Berzi, A., Ferro, S., Lugini, L., Triulzi, T., Tuccitto, A., Tagliabue, E., Castelli, C., & Rivoltini, L. (2017) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2017.03.001 · Cited by 595
Strategies for extended serum half-life of protein therapeutics
Kontermann, R. E. (2011) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2011.06.012 · Cited by 573
Traboulsee, A., Greenberg, B. M., Bennett, J. L., Szczechowski, L., Fox, E., Shkrobot, S., Yamamura, T., Terada, Y., Kawata, Y., Wright, P., et al. (2020) · The Lancet Neurology · doi:10.1016/s1474-4422(20)30078-8 · Cited by 513
Introduction to current and future protein therapeutics: A protein engineering perspective
Carter, P. J. (2011) · Experimental Cell Research · doi:10.1016/j.yexcr.2011.02.013 · Cited by 467
Metadata
- Authors
- Igawa, T., Ishii, S., Tachibana, T., Maeda, A., Higuchi, Y., Shimaoka, S., Moriyama, C., Watanabe, T., Takubo, R., Doi, Y., Wakabayashi, T., Hayasaka, A., Kadono, S., Miyazaki, T., Haraya, K., Sekimori, Y., Kojima, T., Nabuchi, Y., Aso, Y., Kawabe, Y., & Hattori, K.
- Venue
- Nature Biotechnology
- Published
- 2010-10-17
- Volume
- 28
- Issue
- 11
- Pages
- 1203-1207
- ISSN
- 0733-222X (ISSN-L)
- 1087-0156
- 1546-1696
- OpenAlex
- W2021865808
- Cited by
- 353
- References
- 28
- FWCI
- 10.12
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.